Recruiting

Observational Study

Sponsor:

Children's Hospital of Philadelphia

Code:

NCT05250375

Conditions

Primary Mitochondrial Disease

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Accepted

Study Details

Brief summary:

The goal of this observational study is to develop and validate tools to measure disease course in patients with primary mitochondrial myopathy (PMM). The main aims of this study are:

  • Development, validation, and optimization of objective outcome measures for mitochondrial myopathy
  • Defining the natural history of mitochondrial myopathy

Researchers will compare data from patients with primary mitochondrial myopathy to healthy controls. Data from healthy controls will also help define normative data for future studies.

Participants will perform clinical exams of muscle strength and endurance and will complete surveys.

Conditions

Primary Mitochondrial Disease

Study ID

NCT05250375

Start date

Mar 24, 2017

Status verified date

Sep, 2025

Completion date

Mar 24, 2030

Anticipated

Primary completion date

Mar 24, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Accepted

MM Cohort Inclusion Criteria

1. Males or females age 0-100 years of age
2. Mitochondrial disorder established by confirmed genetic or biochemical mutation in mtDNA or nuclear DNA OR is suitable for participation in the opinion of the investigator based on clinical presentation.
3. Exhibits myopathy (exercise intolerance, muscle strength, fatigue) relating to Mitochondrial disease in the opinion of the investigator
4. Able to provide written consent OR parental permission and child assent OR if they are an adult with diminished capacity, an LAR or healthcare representative is able to and willing to provide consent ., as approved by the appropriate Institutional Review Board (IRB) or Ethics Committee (EC)

MM Cohort Exclusion Criteria

1. Male or female fetuses
2. Non English speakers
3. Parents/guardians or subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.
4. Subjects that do not meet all of the enrollment criteria may not be enrolled. Any violations of these criteria must be reported in accordance with IRB Policies and Procedures.

Healthy Control Cohort Inclusion Criteria

1. Males or females age 0-100 years of age
2. No history of mitochondrial myopathy symptoms
3. Able to provide written consent or parental permission and child assent., approved by the appropriate Institutional Review Board (IRB) or Ethics Committee (EC)
4. Individual is not a study staff member or a family member of a study staff member (not listed as a study staff in eIRB)

Healthy Control Exclusion Criteria

1. Male or female fetuses
2. Non English speakers
3. Mitochondrial disorder established by confirmed genetic or biochemical mutation in mtDNA or nuclear DNA
4. Exhibits myopathy (exercise intolerance, muscle strength, fatigue) relating to Mitochondrial disease
5. Parents/guardians or subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.
6. Individual is listed as a study staff member in eIRB, OR individual is a family member of a study staff member listed in eIRB
7. Subjects that do not meet all of the enrollment criteria may not be enrolled. Any violations of these criteria must be reported in accordance with IRB Policies and Procedures.

Study Design

Enrollment

1300 participants

Anticipated

Interventions and Outcome Measures

Arms

Primary Mitochondrial Myopathy

Patients with a mitochondrial disorder established by confirmed genetic or biochemical mutation in mtDNA or nuclear DNA or is suitable for participation in the opinion of the investigator based on clinical presentation and exhibits myopathy (exercise intolerance, muscle strength, fatigue) relating to mitochondrial disease.

Healthy Controls

Males or females age 0-100 years of age with no history of mitochondrial myopathy symptoms.

Primary outcome measure

  • Muscle Strength of MM-COAST [ Time Frame: through study completion, an average of 5 years ]
  • Balance of the MM-COAST [ Time Frame: through study completion, an average of 5 years ]
  • Dexterity of the MM-COAST [ Time Frame: through study completion, an average of 5 years ]
  • Mitochondrial Disease Burden for Adults [ Time Frame: through study completion, an average of 5 years ]
  • Mitochondrial Disease Burden for Children [ Time Frame: through study completion, an average of 5 years ]
  • Challenges in Activities of Daily Life (ADLs) [ Time Frame: through study completion, an average of 5 years ]
  • Functional Tasks of the Mitochondrial Myopathy Functional Scale (MMFS) [ Time Frame: through study completion, an average of 5 years ]
  • Clinical Progression: Survival [ Time Frame: through study completion, an average of 5 years ]
  • Clinical Progression: Growth [ Time Frame: through study completion, an average of 5 years ]
  • Clinical Progression: Other Illnesses [ Time Frame: through study completion, an average of 5 years ]
  • Clinical Progression: Hospitalizations [ Time Frame: through study completion, an average of 5 years ]
  • Clinical Progression: Ambulatory Status [ Time Frame: through study completion, an average of 5 years ]
  • Clinical Progression: Pacemaker Requirement [ Time Frame: through study completion, an average of 5 years ]
  • Clinical Progression: Ventilatory Support [ Time Frame: through study completion, an average of 5 years ]
  • Clinical Progression: Gastrostomy Status [ Time Frame: through study completion, an average of 5 years ]
  • Qualitative Interviews [ Time Frame: through study completion, an average of 5 years ]
  • MM patient-reported outcome measure (PROM), MM-IMPACT [ Time Frame: through study completion, an average of 5 years ]

Central Contacts and Locations

Locations

Children's Hospital of Philadelphia

Recruiting

Philadelphia, Pennsylvania, United States, 19104

Contacts

More Information

Sponsor

Children's Hospital of Philadelphia

Last update posted

Sep 10, 2025

Last verified

Sep, 2025

Keywords

  • Mitochondrial Myopathy
  • Mitochondrial Disease
  • Healthy Volunteers
  • Natural History
  • Muscle Weakness
  • Fatigue
  • Outcome Measures

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Children's Hospital of Philadelphia on 2025-09-10.